Overview
The purpose of this study is to describe the differences in quality of life (QOL) among newly diagnosed patients diagnosed with acute myeloid leukemia (AML) to help design a patient decision-making QOL model for aligning patients' choice of treatment with what matters the most to them.
Eligibility
Inclusion Criteria:
- 60 years of age or older
- Newly diagnosed with pathology-confirmed diagnosis of Acute Myeloid Leukemia
- Within 7 days of starting a new treatment
- Must be able to read and speak English at the 8th grade level
Exclusion Criteria:
- Under 60 years of age
- Other malignancy, dementia, traumatic brain injury or individuals with central nervous system involvement of their leukemia